THE CYSTIC-FIBROSIS HETEROZYGOTE ADVANTAGE

被引：2

作者：

CAMPBELL, H

机构：

来源：

NATURE MEDICINE | 1995年 / 1卷 / 11期

关键词：

D O I：

10.1038/nm1195-1100b

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：1100 / 1100

页数：1

共 9 条

[1]

Garenne Michel, 1992, World Health Statistics Quarterly, V45, P180

[2]

GERGEN PJ, 1995, ASTHMA RHINITIS

[3]

JORDE LB, 1988, AM J HUM GENET, V42, P808

[4] BRONCHIAL-ASTHMA AND HYPERREACTIVITY AFTER EARLY-CHILDHOOD BRONCHIOLITIS OR PNEUMONIA - AN 8-YEAR FOLLOW-UP-STUDY [J].

KORPPI, M ;

KUIKKA, L ;

REIJONEN, T ;

REMES, K ;

JUNTUNENBACKMAN, K ;

LAUNIALA, K .

ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 1994, 148 (10) :1079-1084

[5] HETEROZYGOTES FOR THE DELTA-F508 CYSTIC-FIBROSIS ALLELE ARE NOT PROTECTED AGAINST BRONCHIAL-ASTHMA [J].

MENNIE, M ;

GILFILLAN, A ;

BROCK, DJH ;

LISTON, WA .

NATURE MEDICINE, 1995, 1 (10) :978-979

[6] PRENATAL SCREENING FOR CYSTIC-FIBROSIS [J].

MENNIE, ME ;

GILFILLAN, A ;

COMPTON, M ;

CURTIS, L ;

LISTON, WA ;

PULLEN, I ;

WHYTE, DA ;

BROCK, DJH .

LANCET, 1992, 340 (8813) :214-216

[7]

NEWMANTAYLOR A, 1995, LANCET, V345, P296, DOI 10.1016/S0140-6736(95)90280-5

[8]

ROMAGNANI S, 1993, ASTHMA PHYSL IMMUNOP

[9] PROTECTION AGAINST BRONCHIAL-ASTHMA BY CFTR DELTA-F508 MUTATION - A HETEROZYGOTE ADVANTAGE IN CYSTIC-FIBROSIS [J].

SCHROEDER, SA ;

GAUGHAN, DM ;

SWIFT, M .

NATURE MEDICINE, 1995, 1 (07) :703-705

← 1 →